Nara, Japan

Reiko Shinkura



Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reiko Shinkura: Innovator in Immunomodulation

Introduction

Reiko Shinkura is a notable inventor based in Nara, Japan. She has made significant contributions to the field of immunology, particularly in the development of pharmaceutical compositions aimed at treating allergic diseases. Her innovative work has led to the granting of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Reiko Shinkura holds a patent for an immunomodulator that provides a pharmaceutical composition for the treatment or prophylaxis of allergic diseases. This invention specifically includes a substance that induces selective IgA class switching in B cells. A PKC activator is identified as a potential substance for this purpose. Additionally, her composition can serve as a mucosal adjuvant, enhancing the effectiveness of treatments for allergic conditions.

Career Highlights

Throughout her career, Reiko has worked with esteemed organizations such as Noster Inc. and the Nara Institute of Science and Technology. Her roles in these institutions have allowed her to collaborate with other experts in the field and contribute to groundbreaking research in immunology.

Collaborations

Reiko has collaborated with Kota Yamamoto, a fellow researcher, to further explore the applications of her inventions. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Reiko Shinkura's contributions to immunology through her patent on immunomodulators highlight her role as a leading inventor in the field. Her work not only addresses critical health issues but also paves the way for future advancements in the treatment of allergic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…